Immune-Inflammatory Biomarkers Higher in Severe Mental Illness, T2DM
THURSDAY, Aug. 11, 2022 -- Individuals with severe mental illness or type 2 diabetes mellitus (T2DM) have increased levels of peripheral immune-inflammatory biomarkers, which may contribute to neurocognitive and social deficits, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 11, 2022 Category: Pharmaceuticals Source Type: news

QuickStats: Age-Adjusted Death Rates from Diabetes Mellitus Among Adults Aged ≥65 Years, by Single Race and Hispanic Origin - National Vital Statistics System, United States, 2020
This report describes death rates from diabetes mellitus among U.S. adults aged ≥65 years during 2020. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - August 4, 2022 Category: American Health Tags: Adult Health Data & Stats Diabetes MMWR Morbidity Mortality Weekly Report Senior Health Death Rates Source Type: news

2016 to 2020 Saw Increase in Rates of GDM Across United States
WEDNESDAY, July 20, 2022 -- The rates of gestational diabetes mellitus (GDM) increased from 2016 to 2020, according to the July 19 issue of the National Vital Statistics Reports, a publication from the U.S. Centers for Disease Control and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 20, 2022 Category: Pharmaceuticals Source Type: news

Risks for Diabetes, CVD Up in Acute, Postacute COVID-19 Phases
WEDNESDAY, July 20, 2022 -- The risks for diabetes mellitus (DM) and cardiovascular disease (CVD) are increased in the acute and postacute COVID-19 phases, according to a study published online July 19 in PLOS Medicine. Emma Rezel-Potts, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 20, 2022 Category: Pharmaceuticals Source Type: news

Pregnancy-Associated DM and Stillbirths by Race and Ethnicity Pregnancy-Associated DM and Stillbirths by Race and Ethnicity
This study explored racial and ethnic differences and trends in the prevalence of both preexisting diabetes mellitus and gestational diabetes mellitus.Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 20, 2022 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Consumer Health: What is diabetes insipidus?
Diabetes insipidus is a rare disorder that causes an imbalance of fluids in the body. It's estimated to affect about 1 in 25,000 people worldwide, according to the National Institute of Diabetes and Digestive and Kidney Disease. While the terms "diabetes insipidus" and "diabetes mellitus" sound similar, they're not related. Diabetes mellitus — which involves high blood sugar levels and can occur as Type 1 or Type 2 — is common and often referred to… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 15, 2022 Category: Databases & Libraries Source Type: news

Abdominal CT Biomarkers May Predict Type 2 Diabetes
FRIDAY, July 8, 2022 -- Use of deep learning may identify abdominal computed tomography (CT) biomarkers that can help diagnose type 2 diabetes mellitus at an earlier stage, according to a study published in the July issue of Radiology. Hima Tallam,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 8, 2022 Category: Pharmaceuticals Source Type: news

Author Q & A: Does treatment for gum disease help people with diabetes control blood sugar levels?
We spoke to  Cochrane Oral Health Author Terry Simpson about the updated review Treatment of periodontitis for glycaemic control in people with diabetes mellitus.  He explains the results of this review and what it means for the research community as well as medical, nursing, and dental professionals - with thanks also to Josh Twigg, Ambrina Qureshi, Sarah Wild, Ian Needleman and Laura MacDonald.Terry, can you tell us about this updated Cochrane Review?Our review of studies evaluating the impact of treatment of periodontitis (gum disease) on glycaemic control in people with diabetes was originally published in 2010 (...
Source: Cochrane News and Events - June 16, 2022 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Metformin Use and VTE Risk in Adults With Type 2 Diabetes Metformin Use and VTE Risk in Adults With Type 2 Diabetes
Might metformin use reduce the risk of venous thromboembolism in patients with type 2 diabetes mellitus?American Journal of Epidemiology (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 14, 2022 Category: Intensive Care Tags: Internal Medicine Journal Article Source Type: news

New IMBRUVICA ® (ibrutinib) Data in Fixed-Duration Combination Regimen Presented at EHA 2022 Shows Deep, Durable Response at Three Years in Untreated Chronic Lymphocytic Leukemia
June 10, 2022 (VIENNA) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new and updated results from the Phase 2 CAPTIVATE study evaluating IMBRUVICA® (ibrutinib) in combination with venetoclax (I+V) as a potential fixed-duration (FD) treatment in adult patients with previously untreated chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Updated data from the FD cohort with three years of follow-up shows that I+V continues to demonstrate deep and durable responses and clinically meaningful progression-free survival (PFS) and overall survival (OS) in the first-line tre...
Source: Johnson and Johnson - June 10, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Type 2 Diabetes Tied to Accelerated Brain Aging, Cognitive Decline
WEDNESDAY, June 8, 2022 -- Type 2 diabetes mellitus (T2DM) is associated with neurocognitive changes suggestive of accelerated brain aging, according to a study published online May 24 in eLife. Botond Antal, from Stony Brook University in New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 8, 2022 Category: Pharmaceuticals Source Type: news

Phase 3 SHINE Results Show IMBRUVICA ® (ibrutinib)-Based Combination Regimen Significantly Reduced the Risk of Disease Progression or Death in Older Patients with Newly Diagnosed Mantle Cell Lymphoma
This study is one of the largest clinical trials ever conducted in first-line MCL and the first for a Bruton’s tyrosine kinase inhibitor (BTKi).[1] The data are being presented in an oral session and featured in a press briefing during the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, and were published in The New England Journal of Medicine today. The data will also be presented as an oral presentation at the 2022 European Hematology Association (EHA) Annual Congress. MCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.[2] It commonly affects people o...
Source: Johnson and Johnson - June 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

What Is the Pathophysiology of Type I Diabetes Mellitus?
Title: What Is the Pathophysiology of Type I Diabetes Mellitus?Category: Diseases and ConditionsCreated: 6/3/2022 12:00:00 AMLast Editorial Review: 6/3/2022 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - June 3, 2022 Category: Endocrinology Source Type: news

What Is the Pathogenesis of Types I and II Diabetes Mellitus?
Title: What Is the Pathogenesis of Types I and II Diabetes Mellitus?Category: Diseases and ConditionsCreated: 6/3/2022 12:00:00 AMLast Editorial Review: 6/3/2022 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - June 3, 2022 Category: Endocrinology Source Type: news

Gestational Diabetes Linked to Pregnancy Complications
THURSDAY, June 2, 2022 -- Gestational diabetes mellitus is significantly associated with pregnancy complications when adjusting for confounding variables, according to research published online May 25 in The BMJ. Wenrui Ye, from Central South... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 2, 2022 Category: Pharmaceuticals Source Type: news